Transfected human B cells: A new model to study the functional and immunostimulatory consequences of APP production

Experimental Gerontology

Volumn 34, Issue 6, 1999, Pages 783-795

  Marx, F ^a   Blasko, I ^a   Zisterer, K ^a   Grubeck Loebenstein, B ^a  

^a Inst Biomed Aging Res Austrian A   (Austria)

Author keywords

Alzheimer's disease; Amyloid ; Apoptosis; APP; Cell proliferation; Lymphocytes

Indexed keywords

AMYLOID PRECURSOR PROTEIN;

ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; CYTOCHEMISTRY; EPSTEIN BARR VIRUS; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MUTATION; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; VIRUS CELL TRANSFORMATION;

AMYLOID BETA-PROTEIN PRECURSOR; APOPTOSIS; AUTOANTIGENS; B-LYMPHOCYTES; CELL DIVISION; CELL LINE, TRANSFORMED; HUMANS; MODELS, BIOLOGICAL; T-LYMPHOCYTES; TRANSFECTION;

HUMAN HERPESVIRUS 4;

EID: 0032820947     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0531-5565(99)00049-2     Document Type: Article

References (42)

1. Araki W., Kitaguchi N., Tokushima Y., et al. Trophic effect of beta-amyloid precursor protein on cerebral cortical neurons in culture. Biochem Biophys Res Commun. 181:1991;265-271.
2. Beatty P.R., Krams S.M., Martinez O.M. Involvement of IL-10 in the autonomous growth of EBV-transformed B cell lines. J Immunol. 158:1997;4045-4051.
3. Blasko I., Schmitt T.L., Steiner E., Trieb K., Grubeck-Loebenstein B. Tumor necrosis factor a augments amyloid b protein (25-35) induced apoptosis in human cells. Neurosci Lett. 238:1997;17-20.
4. Bullido M.J., Munoz-Fernandez M.A., Recuero M., Fresno M., Valdivieso F. Alzheimer's amyloid precursor protein is expressed on the surface of hematopoietic cells upon activation. Biochim Biophys Acta. 1313:1996;54-62.
5. Bush A.I., Martins R.N., Rumble B., et al. The amyloid precursor protein of Alzheimer's disease is released by human platelets. J Biol Chem. 265:1990;15977-15983.
6. Buxbaum J.D., Gandy S.E., Cicchetti P., et al. Processing of Alzheimer β/A4 amyloid precursor protein modulation by agents that regulate protein phosphorylation . Proc Natl Acad Sci USA. 87:1990;6003-6006.
7. Cann A.J., Koyanagi Y., Chen I.S.Y. Efficient electroporation of primary human lymphocytes. Oncogene. 3:1988;123-128.
8. Chartier-Harlin M.C., Crawford F., Houlden H. Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene. Nature (Lond). 353:1991;844-846.
9. Citron M., Oltersdorf T., Haass C., et al. Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production. Science. 360:1992;672-674.
10. Cook D.G., Forman M.S., Sung J.C., et al. Alzheimer's Aβ(1-42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells. Nat Med. 3:1997;1021-1023.
11. Esch F.S., Keim P.S., Beattie E.C., et al. Cleavage of amyloid β-protein during constitutive processing of its precursor. Science. 248:1990;1122-1124.
12. Essalmani R., Macq A.F., Mercken L., Octave J.N. Missense mutations associated with familial Alzheimer's disease in Sweden lead to the production of the amyloid peptide without internalization of its precursor. Biochem Biophys Res Commun. 218:1996;89-96.
13. Goate A., Chartier-Harlin M.C., Mullan M., et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature (Lond). 349:1991;704-706.
14. Goldgaber D., Harris H.W., Hla T., et al. Interleukin 1 regulates synthesis of amyloid β-protein precursor mRNA in human endothelial cells. Proc Natl Acad Sci USA. 86:1989;7606-7610.
15. + and specifically recognize autologous fibrobroblasts. J Clin Invest. 93:1994;2738-2743.
16. Haas C., Schlossacher M.G., Hung A.Y., et al. Amyloid β-peptide is produced by cultured cells during normal metabolism. Nature (Lond). 359:1992;322-327.
17. Iversen L.L., Mortishire-Smith J., Pollack S.J., Shearman M.S. The toxicity in vitro of β-amyloid protein. Biochem J. 311:1995;1-16.
18. Jackson M.R., Nilsson T., Peeterson P.A. Identification of a consensus motif for retention of transmembrane proteins in the endoplasmic reticulum. EMBO J. 9:1990;3153-3162.
19. Jin L.W., Ninomiya H., Roch J.M., et al. Peptides containing the RERMS sequence of amyloid β/A4 protein precursor bind cell surface and promote neurite extension. J Neurosci. 14:1994;5461-5470.
20. Kang J., Lemaire H.G., Unterbeck A., et al. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature (Lond). 325:1987;733-736.
21. Kim K.S., Miller D.L., Sapienza V.J., et al. Production and characterization of monoclonal antibodies reactive to synthetic cerebrovascular amyloid peptide. Neurosci Res Commun. 2:1988;121-130.
22. Kim K.S., Wen G.Y., Bancher C., et al. Detection and quantitation of amyloid β-peptide with 2 monoclonal antibodies. Neurosci Res Commun. 7:1990;113-122.
23. Lannfelt L., Basun H., Wahlund L.O., Rowe B.A., Wagner S.L. Decreased α-secretase-cleaved amyloid precursor protein as a diagnostic marker for Alzheimer's disease. Nat Med. 1:1995;829-832.
24. Lorenzo A., Yankner B.A. β-Amyloid neurotoxicity requires fibril formation and is inhibited by congo red. Proc Natl Acad Sci USA. 91:1994;12243-12247.
25. Marx F., Blasko I., Pavelka M., Grubeck-Loebenstein B. The possible role of the immune system in Alzheimer's disease. Exp Gerontol. 7/8:1998;871-881.
26. 2+ homeostasis in Alzheimer's disease. Trends Neurosci. 16:1993;409-414.
27. Mönning U., König G., Prior R., et al. Synthesis and secretion of Alzheimer amyloid Aβ4 precursor protein by stimulated human peripheral blood leucocytes. FEBS Lett. 277:1990;261-266.
28. Mullan M., Crawford F., Axelman K., et al. A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of β-amyloid. Nat Genet. 1:1992;345-347.
29. Murrell J., Farlow M., Ghetti B., Bensonl M.D. A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. Science. 254:1991;97-99.
30. Neitzel H. A routine method for the establishment of permanent growing lymphoblastoid cell lines. Hum Genet. 73:1986;320-326.
31. Nicoletti I., Migliorati G., Pagliacci M.C., Grigniani F., Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods. 139:1991;271-279.
32. Niederwolfsgruber E., Schmitt T.L., Blasko I., et al. The production of the Alzheimer amyloid precursor protein (APP) in extraneuronal tissue does not increase in old age. J Gerontol. 53:1998;186-190.
33. Pietrzik C.U., Hoffmann J., Stöber K., et al. From differentiation to proliferation the secretory amyloid precursor protein as a local mediator of growth in thyroid epithelial cells . Proc Natl Acad Sci USA. 95:1998;1770-1775.
34. Saitoh T., Sundsmo M., Roch J.M., et al. Secreted form of amyloid b protein precursor is involved in the growth regulation of fibroblasts. Cell. 58:1989;615-622.
35. Schmitt T.L., Sztankay A., Steiner E., Klingler P., Trieb K., Grubeck-Loebenstein B. Interferon-γ inhibits production and metabolism of amyloid precursor protein in human extraneuronal cells. Iqbal K., Winblad B., Nishimura T., Takeda M., Wisniewsky H.M. Alzheimer's Disease Biology, Diagnosis and Therapeutics . 1997;429-435 John Wiley and Sons, Chichester.
36. Schubert D., Cole G., Saitoh T., Oltersdorf D. Amyloid β protein precursor is a mitogen. Biochem Biophys Res Commun. 162:1989;83-88.
37. Schubert D., Behl C. The expression of amyloid β protein precursor protects nerve cells from β-amyloid and glutamate toxicity and alters their interaction with the extracellular matrix. Brain Res. 629:1993;275-282.
38. Selkoe D.J., Podlisny M., Joachim C., et al. β-Amyloid precursor protein occurs as 110 to 135 kilodalton membrane-associated proteins in neural and nonneural tissues. Proc Natl Acad Sci USA. 85:1988;7341-7345.
39. Selkoe D.J. Cell biology of the amyloid β-protein precursor and the mechanism of Alzheimer's disease. Annu Rev Cell Biol. 10:1994;373-403.
40. Tienari P.J., Ida N., Ikonen E., et al. Intracellular and secreted Alzheimer β-amyloid species are generated by distinct mechanisms in cultured hippocampal neurons. Proc Natl Acad Sci USA. 94:1997;4125-4130.
41. Trieb K., Ransmayr G., Sgonc R., Lassmann H., Grubeck-Loebenstein B. APP peptides stimulate lymphocyte proliferation in normals, but not in patients with Alzheimer's disease. Neurobiol Aging. 17:1996;541-547.
42. Wild-Bode C., Yamazaki T., Capell A., et al. Intracellular generation and accumulation of amyloid-β peptide terminating at amino acid 42. J Biol Chem. 272:1997;16085-16088.